Middle East Midline Catheters Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The Middle East and Africa catheter market represents a diverse segment of the global medical devices industry, covering vascular access and interventional products such as midline catheters, diagnostic catheters, balloon catheters, drainage catheters, and general plastic catheters. The MEA plastic catheter market alone generated revenues of approximately $285 million in 2024, while the broader global catheter industry, from which regional demand is derived, reached roughly $22.8 billion in 2025. The global midline catheter segment, a key product category used extensively throughout MEA hospitals for intermediate-duration intravenous therapy, was valued at approximately $1.26 billion in 2024 and is expanding alongside the overall catheter market's projected growth to $36 billion by 2030.

• •The MEA plastic catheter market reached approximately $285 million in 2024, with the region's catheter demand embedded in the broader global market valued at $22.8 billion in 2025
• •The global midline catheter segment, a key product class used across MEA healthcare facilities, was valued at approximately $1.26 billion in 2024, with growth tracking the overall catheter market's trajectory toward $36 billion by 2030
• •The MEA catheter market is expected to add more than $1.40 billion in cumulative value during the 2025-2030 forecast period, reflecting expanding healthcare utilization across the region

The primary engine of market expansion is the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer, which increases demand for catheter-based interventions and long-term vascular access solutions across MEA healthcare systems. Expanding healthcare infrastructure investment, particularly in Gulf Cooperation Council nations and major African economies, is driving hospital construction, equipment procurement, and procedural volume growth. Demographic trends including aging populations and growing patient cohorts requiring dialysis, chemotherapy, and parenteral nutrition are creating sustained demand for catheter products, while improved reimbursement frameworks and rising healthcare spending per capita are enabling broader adoption.

• •Rising chronic disease burden across MEA, including cardiovascular conditions, diabetes, and cancer, is increasing procedural volumes and long-term catheter demand in hospitals and ambulatory settings
• •Ongoing healthcare infrastructure investments and hospital capacity expansions across GCC countries and emerging African markets are driving equipment procurement and procedural adoption
• •Aging populations, growing dialysis and chemotherapy patient populations, and rising healthcare expenditure per capita are expanding the addressable patient base for catheter products

The MEA catheter market is segmented across multiple product types, with significant submarkets including diagnostic catheters valued at approximately $340 million in 2025, balloon catheters projected to grow from roughly $189 million in 2024 to over $271 million by 2032, and drainage catheters as part of a global segment valued at approximately $2.2 billion in 2025. Regional demand concentration is highest in the GCC nations, particularly Saudi Arabia, the United Arab Emirates, and Qatar, where healthcare spending and medical tourism are most developed, while Sub-Saharan Africa represents an emerging opportunity with growing investment in basic and intermediate healthcare infrastructure. The MEA plastic catheter submarket is projected to grow at a 3.5% CAGR through 2030, reflecting more moderate but stable expansion compared to higher-growth interventional segments.

• •Diagnostic catheters in MEA were valued at approximately $340 million in 2025, while the balloon catheter segment is projected to grow from roughly $189 million in 2024 to over $271 million by 2032, driven by interventional cardiology and radiology procedures
• •The GCC region, led by Saudi Arabia, UAE, and Qatar, dominates current catheter demand due to established healthcare infrastructure and medical tourism, while Sub-Saharan Africa represents a growing opportunity segment
• •The MEA plastic catheter market is expected to grow at a 3.5% CAGR through 2030, with the broader MEA catheter market projected to contribute more than $1.40 billion in cumulative value during 2025-2030

Who are the notable companies in the industry?

The Middle East midline catheters market is shaped by three dominant players, each leveraging distinct technical and operational strengths. Becton Dickinson dominates hospital procurement channels across the Gulf Cooperation Council states through its integrated manufacturing scale, enabling efficient supply to tertiary care networks. Teleflex maintains technology leadership by specializing in power-injectable catheter designs optimized for contrast-enhanced imaging protocols, aligning with rising CT angiography demand. B. Braun anchors its position through proprietary polyurethane formulations engineered to meet regional durability requirements under SFDA and MOHAP mandates, ensuring compliance with strict biocompatibility and kink-resistance standards. Together, these firms cater to a market increasingly driven by institutional efforts to reduce central line-associated infections, with demand concentrated in Saudi Arabia and the UAE. The competitive landscape is further reconfigured by asset-light leasing models, though only these three players are explicitly identified in the research as having defined, verified roles: Becton Dickinson as the procurement-scale leader, Teleflex as the innovation driver in imaging-compatible devices, and B. Braun as the materials specialist meeting localized clinical and regulatory demands. Their combined focus on polyurethane-based, power-injectable, and durable catheters reflects the market’s technical evolution toward safer, high-performance vascular access solutions.

• •The market features a mix of large diversified medical device manufacturers and specialty producers, with moderate global consolidation alongside regional fragmentation, particularly in emerging MEA markets where local distributors play significant roles
• •Production relies on polymer extrusion, precision machining, and advanced coating technologies, with product differentiation driven by material science innovations such as hydrophilic coatings, antimicrobial treatments, and pressure-sensing capabilities
• •Global manufacturing capacity is concentrated in established medical device production regions, with market participation in MEA dependent on regulatory compliance capabilities, distribution partnerships, and localized service infrastructure

What are the recent trends and outlook?

Technological innovation is reshaping catheter design toward safer, more efficient products, with emphasis on infection prevention, patient comfort, and procedural efficiency driving product development priorities across manufacturers. Antimicrobial and antibiotic-impregnated catheter technologies are gaining traction as healthcare-associated infection prevention becomes an increasingly prominent quality metric, while digital integration and pressure monitoring capabilities are expanding the functionality of advanced catheter systems. Market expansion in MEA is expected to accelerate as healthcare systems modernize, insurance coverage broadens, and clinical protocols increasingly favor catheter-based interventions over alternative approaches. The trajectory suggests sustained mid-to-high single-digit growth through the forecast horizon, with the global catheter market projected to reach approximately $36 billion by 2030, supported by demographic, technological, and access-related tailwinds.

• •Antimicrobial coatings, infection-prevention technologies, and pressure-monitoring integration are emerging as key product differentiation factors, aligning with global healthcare quality priorities and infection control mandates
• •Healthcare system modernization, expanding insurance coverage, and evolving clinical protocols favoring minimally invasive catheter-based procedures are expected to accelerate MEA market growth through the 2030 forecast period
• •The global catheter market is projected to reach approximately $36 billion by 2030, representing sustained expansion from the 2025 baseline of roughly $22.8 billion, with MEA participation growing as regional healthcare access and procedural volumes increase